Diffuse uerine leiomyomatosis complicated with cerebral thrombosis after oral contraceptive treatment：a case report of athletic patients

• Qimin Zhou ^[1] ; Xiaohong Chen ^[1] ; Huifang Wu ^[1] ; Shouye Ma ^[1] ; Qin Wang ^[1]
  1. [1] Gansu Provincial Hospital

     Gansu Provincial Hospital

     China

     
• Localización: Revista Internacional de Medicina y Ciencias de la Actividad Física y del Deporte, ISSN-e 1577-0354, Vol. 23, Nº. 90, 2023, págs. 85-96
• Idioma: español
• Enlaces
  • Texto completo
• Resumen

  • We would like to emphasize the differentiations of diagnosis and treatment between general uterine leiomyomas and diffuse uterine leiomyomatosis (DUL), which is a kind of extremely rare disease. Levonorgestrel-releasing intrauterine system (LNG-IUS) is an attainable option provided to treat DUL with cerebral thrombosis, as a feasible novel method. Case report: A 21-year-old female patient with DUL was due to cerebral venous thrombosis caused by oral contraceptives. The patient was persistently vaginal bleeding after decreasing intracranial pressure and anticoagulant therapy for 3 days. Subsequently, a hysteroscopic submucosal myomectomy was performed to restore the normal shape of the uterine cavity, and the placement of Mirena was given after surgery, which aimly played a good role in hemostasis, prevention of severe menorrhagia and reconstruction of endometrial function. Conclusion: This case report shows that, levonorgestrel-releasing intrauterine system (LNG-IUS) is efficient and secure to treat DUL after hysteroscopic surgery, and simultaneously does not increase the risk of venous thromboembolism (VTE).